CORC

在结果中检索

CORC

浏览/检索结果: 共25条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Low molecular weight fucoidan restores diabetic endothelial glycocalyx by targeting neuraminidase2: A new therapy target in glycocalyx shedding 期刊论文
BRITISH JOURNAL OF PHARMACOLOGY, 2024, 页码: 17
作者:  Li, Zhi;  Wu, Ning;  Wang, Jing;  Yue, Yang;  Geng, Lihua
收藏  |  浏览/下载：5/0  |  提交时间：2024/04/07
Pharmacokinetics of fucoidan and low molecular weight fucoidan from Saccharina japonica after oral administration to mice 期刊论文
JOURNAL OF OCEANOLOGY AND LIMNOLOGY, 2023, 页码: 10
作者:  Tan, Jiaojiao;  Song, Yimin;  Wang, Jing;  Wu, Ning;  Yue, Yang
收藏  |  浏览/下载：23/0  |  提交时间：2023/12/13
Advanced glycation end products via skin autofluorescence as potential marker of carotid atherosclerosis in patients with type 2 diabetes 期刊论文
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 卷号: 31
作者:  Ying, Lingwen;  Shen, Yun;  Zhang, Yang;  Wang, Yikun;  Liu, Yong
收藏  |  浏览/下载：29/0  |  提交时间：2022/01/10
Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications 期刊论文
FRONTIERS IN PHARMACOLOGY, 2020, 卷号: 11, 页码: 13
作者:  Li, Zhi;  Wu, Ning;  Wang, Jing;  Zhang, Quanbin
收藏  |  浏览/下载：132/0  |  提交时间：2021/04/12
Lower BMI is of not more benefit to diabetic complications. 期刊论文
Journal of diabetes investigation, 2019
作者:  Yongze Zhang;  Yangyang Guo;  Ximei Shen;  Fengying Zhao;  Yan Sunjie
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/13
Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis 期刊论文
Vascular pharmacology, 2018, 卷号: 101, 页码: 29-37
作者:  Mei, Xiyu;  Zhou, Lingyu;  Zhang, Tianyu;  Lu, Bin;  Sheng, Yuchen
收藏  |  浏览/下载：52/0  |  提交时间：2019/01/08
Involvement of growth factors in diabetes mellitus and its complications: A general review 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2018, 卷号: 101, 页码: 510-527
作者:  Shi, Guang-Jiang;  Shi, Guang-Rui;  Zhou, Jia-yin;  Zhang, Wen-jin;  Gao, Chen-ying
收藏  |  浏览/下载：2/0  |  提交时间：2019/11/26
Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications. 期刊论文
Frontiers in pharmacology, 2018, 页码: 1422
作者:  He Fazhong;  Shu Yan;  Wang Xingyu;  Liu Xin;  Liu Guojing
收藏  |  浏览/下载：8/0  |  提交时间：2019/02/25
Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications 期刊论文
Frontiers in Pharmacology, 2018, 卷号: Vol.9
作者:  Fazhong He;  Yan Shu;  Xingyu Wang;  Xin Liu;  Guojing Liu
收藏  |  浏览/下载：16/0  |  提交时间：2019/02/25
Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications 期刊论文
Frontiers in Pharmacology, 2018, 卷号: Vol.9
作者:  Fazhong He;  Yan Shu;  Xingyu Wang;  Xin Liu;  Guojing Liu
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace